EP3656373

Sprauta

  • Status:
    EP Einkaleyfi fallið úr gildi
  • EP appl. date:
    25.1.2013
  • EP published:
    16.2.2022
  • EP application number:
    19210117.8
  • Max expiry date:
    24.1.2033
  • Title in English:
    SYRINGE
  • Language of the patent:
    English

Timeline

Today
25.1.2013EP application
16.2.2022EP Publication
3.5.2022Translation submitted
15.6.2022Registration published

Owner

  • Name:
    Novartis AG
  • Address:
    Lichtstrasse 35, 4056 Basel, CH

Inventor

  • Name:
    SIGG, Juergen
  • Address:
    4002 Basel, CH
  • Name:
    ROYER, Christophe
  • Address:
    4002 Basel, CH
  • Name:
    BRYANT, Andrew Mark
  • Address:
    4002 Basel, CH
  • Name:
    BUETTGEN, Heinrich Martin
  • Address:
    4002 Basel, CH
  • Name:
    PICCI, Marie
  • Address:
    4002 Basel, CH

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    12174860
  • Date:
    3.7.2012
  • Country:
    EP
  • Number:
    12189649
  • Date:
    23.10.2012
  • Country:
    EP
  • Number:
    202012011016 U
  • Date:
    16.11.2012
  • Country:
    DE
  • Number:
    2012101677
  • Date:
    16.11.2012
  • Country:
    AU
  • Number:
    2012101678
  • Date:
    16.11.2012
  • Country:
    AU
  • Number:
    202012011260 U
  • Date:
    23.11.2012
  • Country:
    DE
  • Number:
    202012011259 U
  • Date:
    23.11.2012
  • Country:
    DE
  • Number:
    12195360
  • Date:
    3.12.2012
  • Country:
    EP
  • Number:
    202013000688 U
  • Date:
    23.1.2013
  • Country:
    DE
  • Number:
    2013100071
  • Date:
    23.1.2013
  • Country:
    AU
  • Number:
    2013100070
  • Date:
    23.1.2013
  • Country:
    AU

Classification

  • Categories:
    A61J 9/00, A61M 5/31, A61M 5/315, A61M 5/28, A61F 9/00, A61K 9/00, A61K 38/17, A61M 5/178, A61P 9/00, A61P 9/10, A61P 27/02, A61P 35/00, A61P 43/00

Upload documents